News AngioGenex, Inc.

Equities

Delayed OTC Markets Other stock markets			5-day change	1st Jan Change
- ^USD	-.--%		-.--%	-99.85%

ANGIOGENEX, INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities (form 8-K)	21-12-16	AQ
ANGIOGENEX, INC. : Change in Directors or Principal Officers (form 8-K)	20-07-13	AQ
ANGIOGENEX, INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	20-02-11	AQ
ANGIOGENEX INC COM USD0.001 : AngioGenex Reviews 2008 Achievements and Sets Goals for 2009	08-11-25	PR
ANGIOGENEX INC COM USD0.001 : AngioGenex Appoints New CEO to Direct Development of Anti-Cancer Drugs	08-06-10	PR

No results for this search